Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
89°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunovant Inc
(NQ:
IMVT
)
32.42
+1.02 (+3.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunovant Inc
< Previous
1
2
3
4
5
Next >
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Immunovant: Here's What You Need To Know
May 23, 2023
Via
Benzinga
Immunovant Inc. (NASDAQ: IMVT) is a Stock Spotlight on 5/23
May 23, 2023
Via
Investor Brand Network
Analyst Expectations for Immunovant's Future
May 23, 2023
Via
Benzinga
Recap: Immunovant Q4 Earnings
May 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
May 01, 2023
Via
Benzinga
Analyst Expectations for Immunovant's Future
April 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023
April 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
March 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
March 30, 2023
Via
Benzinga
7 Analysts Have This to Say About Immunovant
March 30, 2023
Via
Benzinga
Immunovant Inc. (NASDAQ: IMVT) is a Stock Spotlight on 3/24
March 24, 2023
Via
Investor Brand Network
Analyst Boosts Immunovant Price Target After Updated Pipeline Realignment
March 20, 2023
Via
Benzinga
Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
February 13, 2023
Via
Benzinga
Analyst Expectations for Immunovant's Future
February 07, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Immunovant
November 08, 2022
Within the last quarter, Immunovant (NASDAQ:IMVT) has observed the following analyst ratings:
Via
Benzinga
Where Immunovant Stands With Analysts
November 07, 2022
Immunovant (NASDAQ:IMVT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via
Benzinga
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
December 23, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Immunovant: Q2 Earnings Insights
November 04, 2022
Immunovant (NASDAQ:IMVT) reported its Q2 earnings results on Friday, November 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Immunovant Stock Is Skyrocketing This Week
October 06, 2022
The drugmaker announced a $75 million public offering.
Via
The Motley Fool
6 Analysts Have This to Say About Immunovant
November 08, 2022
Over the past 3 months, 6 analysts have published their opinion on Immunovant (NASDAQ:IMVT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th
November 07, 2022
From
Immunovant Inc.
Via
GlobeNewswire
Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022
November 04, 2022
From
Immunovant Inc.
Via
GlobeNewswire
Why Sotera Health Shares Are Trading Lower By Around 13%, Here Are 38 Stocks Moving In Wednesday's Mid-Day Session
October 05, 2022
Gainers Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 104% to $2.9201. Shares of this low-float penny stock closed up about 80% on Tuesday.
Via
Benzinga
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
October 06, 2022
Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.
Via
Benzinga
RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday
October 05, 2022
U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
October 05, 2022
Palm Beach, FL – October 5, 2022 – FinancialNewsMedia.com News Commentary – Advanced pancreatic ductal adenocarcinoma (PDAC) remains a significant cause of mortality accounting for up to 4% of all...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
S&P 500 Rises 100 Points; Nasdaq Up 3%
October 04, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing more than 300 points on Tuesday.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.